Herve Hoppenot

Herve Hoppenot

Director/Board Member at BICYCLE THERAPEUTICS PLC

Net worth: 10 M $ as of 29/09/2026

66 year
Health Technology
Commercial Services
Process Industries

Profile

Herve Hoppenot holds the position of Chairman, President & Chief Executive Officer of Incyte Corp. He is also on the board of Biotechnology Innovation Organization, Cellectis SA and Pharmaceutical Research & Manufacturers of America. In his past career he was President at Novartis Oncology, Inc., President for Novartis Pharmaceuticals Corp., Head-US Oncology Business Unit at Aventis SA, Vice President-Oncology Division at Aventis Pharmaceuticals, Inc., Principal at Rhone Poulenc AG, Inc. and Head-US Oncology Business Unit at Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 83,411 ( 0.04% ) 10 M $ 29/09/2026
12/04/2026 13,258 ( 0.03% ) 48 789 $ 29/09/2026
-.--%
07/06/2026 0 ( -.--% ) - $ 29/09/2026

Herve Hoppenot active positions

CompaniesPositionStart
BICYCLE THERAPEUTICS PLC Director/Board Member 07/09/2025
Director/Board Member -
Director/Board Member -
Director/Board Member 31/10/2021
Chairman 05/10/2025

Former positions of Herve Hoppenot

CompaniesPositionEnd
INCYTE CORPORATION Chief Executive Officer 25/06/2025
CELLECTIS S.A. Director/Board Member 26/06/2023
President 31/12/2013
President 31/12/2013
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Herve Hoppenot's experience

Education of Herve Hoppenot

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Health Technology

Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Herve Hoppenot